Drugs / HLA mismatched stem cell
last change May 2013 re-read 3 minutes ago

HLA mismatched stem cell

Cell therapy

Developed for
acute myeloid leukemia
Investigated by
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences

Trials 1

200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT02461121 May 2004 → May 2013 acute myeloid leukemia The Affiliated Hospital of the Chinese Academy of Military Medical Sciences Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as HLA mismatched stem cell ClinicalTrials.gov intervention name — accepted as the source's own label NCT02461121 ↗
Modality Cell therapy “HLA mismatched donor G-CSF mobilized peripheral stem cell infused 24 hours (day 0) after the completion of chemotherapy” NCT02461121 ↗
Route Other “HLA mismatched donor G-CSF mobilized peripheral stem cell infused 24 hours (day 0) after the completion of chemotherapy” NCT02461121 ↗